baber/WOPTO huggingface dataset:
Patent CA-1308277-C (CA)
Title: Driver for framer's and glazier's points
Inventor: KOZYRSKI VINCENT T
IPC: B25C1/02
Filed: 1991-04-11
Granted: 1992-10-06
Abstract: ABSTRACT OF THE DISCLOSURE     A machine for driving glazier s and framer's points utilizes a push plate which is effective to drive the points at both of two levels.   A ramp element is incorporated, which serves to deflect the points from an upper to an lower level as they are being driven forwardly into the workpiece, and edge features of the points employed impart a rotation or turning action thereto which deflects the tail portions downwardly to bear tightly upon the glass plate or other piece that is being mounted.  Features of the points cooperate with elements of the magazine to ensure proper orientation, and the machine is effective and comfortable to use.
Patent DK-165980-C (DK)
Inventor: SHIM JOOSUP
IPC: C10M133/44
Filed: 1984-08-30
Granted: 1993-07-26
Abstract: Synthesized- and mineral-based industrial lubricants are stabilized with a triazole adduct of amine phosphates thereby providing excellent oxidation stability, antiwear and rust preventative performance for said industrial lubricants.
Patent FI-91413-C (FI)
Inventor: RIVIER CATHERINE LAURE
IPC: C07K1/02
Filed: 1985-10-22
Granted: 1994-06-27
Abstract: Agonists of rCRF and oCRF are disclosed that can be administered to achieve a substantial elevation of ACTH. ß-endorphin, ß-lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. One agonist which has been found to be particularly potent is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH<sub>2</sub>. In the agonists, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and cr by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. Similar peptides which function as CRF antagonists are ceated by deleting the first 7, 8 or 9 N-terminal residues. These analogs or pharmaceuncally or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier can be administered to mammals, including humans The agonists may also be used as stimulants to elevate mood and improve memory and teaming, as well as diagnostically. The antagonists can be used to lower stress.
Patent FI-78055-C (FI)
Inventor: NINANE LEON
IPC: C01D7/37
Filed: 1986-01-29
Granted: 1989-06-12
Abstract: 1. Process for manufacturing dense anhydrous sodium carbonate, according to which light anhydrous sodium carbonate (2) is added to an aqueous sodium carbonate solution (6) and the resulting mixture (1) is treated within a temperature range above the transition temperature of sodium carbonate monohydrate to anhydrous sodium carbonate, characterized in that a saturated aqueous sodium carbonate solution (6) is employed, the addition of the light anhydrous sodium carbonate (2) to the said solution is performed within the abovementioned temperature range and the resulting aqueous suspension is subjected to a maturing treatment within this temperature range.
Patent FI-79768-C (FI)
Inventor: LABEDZ GERALD PAUL
IPC: H04B7/26
Filed: 1986-03-12
Granted: 1991-11-05
Abstract: A data message transmission system for a cellular radiotelephone system is disclosed. Data to be transmitted is converted into a format compatible with radio transmission prior to transmission. The data is reconverted to its original format following reception. Handoff is accomplished by halting the data transmission prior to handoff and resuming data transmission after handoff. Call supervision occurs via busy-idle bit coding.
Patent FI-94133-C (FI)
Inventor: KANEKO MASAKATSU
IPC: C07D233/54
Filed: 1986-04-18
Granted: 1995-07-25
Abstract: New griseolic acid derivatives have various groups attached to the sugar part in place of the adenine group of griseolic acid itself. These groups are all purine derivatives or ring-opened purine analogs. The compounds are useful as inhibitors of phosphodiesterases. They may be prepared by replacing the adenine moiety of griseolic acid and/or dihydrodesoxygriseolic acid and/or by replacing other substituent groups.
Patent FI-93743-C (FI)
Inventor: GINGERAS RAYMOND THOMAS
IPC: C12Q1/68
Filed: 1989-12-19
Granted: 1995-05-26
Abstract: A method of amplifying a target sequence in a sample containing nucleic acid is provided which comprises hybridizing to the target sequence a first nucleic acid primer including a promoter sequence, extending the primer in a polymerase extension reaction complementarily to the target sequence to form a duplex, rendering the duplex single stranded, hybridizing to the extension product containing the promoter a second primer and carrying out a second extension reaction, and employing the second duplex as a template for the production of a plurality of RNA transcripts, the method being characterised in that the first and/or second primer includes a sequence necessary to allow the RNA product to be replicated by replicase induction and in that the RNA transcripts are so replicated.
Patent NO-164594-C (NO)
Inventor: CHRISTENSEN JOERGEN ANDERS
IPC: C07C57/00
Filed: 1984-03-06
Abstract: A mixture of enantiomers of trans-3-[(4-methoxyphenoxy)-methyl]-1-methyl-4-phenylpiperidine is separated into the optically active pure forms by reacting it with an enantiomer of mandelic acid or a derivative thereof to form two diastereomeric compounds and by precipitating one of the diastereomeric compounds formed. The precipitated compound is subsequently separated and is optionally converted into the free base or a pharmaceutically acceptable salt thereof. The yield obtained is substantially higher than the yield obtained by a prior art process employing a tartaric acid derivative as resolving agent.
Patent NO-156677-C (NO)
Inventor: SIMENSEN PER ARNE
IPC: E02B17/00
Filed: 1984-09-21
Abstract: PCT No. PCT/NO85/00056 Sec. 371 Date May 20, 1986 Sec. 102(e) Date May 20, 1986 PCT Filed Sep. 18, 1985 PCT Pub. No. WO86/01752 PCT Pub. Date Mar. 27, 1986.A method for providing a tubular node in framework truss structures, such as offshore platforms for oil drilling and production activities of the type consisting of interconnected legs and braces of steel tube elements. For formation of the transition between leg and brace in the node is utilized a blank of rolled plate steel, which is given the desired curved shape corresponding to the curvature of the leg. The blank is pressed or extruded in a suitable press tool formed with an outwardly extending brace stub at the desired angle, which brace stub is designed for welding to a complementary brace tubing in the framework. Thereafter, the blank with the brace stub is welded into the leg proper and constitutes a wall segment of the leg in the node.
Patent NO-174207-C (NO)
Inventor: JUNG GUNTHER
IPC: A61K47/48
Filed: 1986-06-23
Abstract: Conjugates are described in which the active ingredient is covalently bonded to the anchoring membrane, which is a compound of the formulae   <IMAGE> in which A can be: sulphur, oxygen, disulphide (-S-S-), methylene (-CH2-) or -NH-; n = 0 to 5; m = 1 or 2; C* = an asymmetric carbon atom of R or S configuration, R, R' and R'' are identical or different and are an alkyl, alkenyl or alkynyl group having 7 to 25 carbon atoms or are hydrogen which can optionally be substituted by hydroxyl, amino, oxo, acyl, alkyl or cycloalkyl groups and R1 and R2 are identical or different and are defined as R, R' or R'' or can be -OR, -OCOR, -COOR, -NHCOR or -CONHR and X is an active ingredient or a spacer active ingredient group. The anchoring membrane active ingredient conjugates increase antibody formation.
Patent NO-167590-C (NO)
Inventor: GILMAN PAUL S
IPC: B22F9/04
Filed: 1986-12-15
Abstract: Precursor alloys for subsequent mechanical alloying into a final alloy, pref. a Al 4% Ti alloy, are formed by: a) forming a first blend of the principal (I) and secondary (II) elements (Al and Ti respectively) in a proportion equivalent to the compsn. of an intermetallic cpd. formed by (I) and (II), the percentage of the secondary element in the precursor alloy is in excess of that in the final alloy; b) mechanically alloying the first blend; c) adding an additional quantity of the principal element to b), to raise the percentage of the element in the final alloy, to form a second blend; and d) mechanically alloying the second blend. Pref. the first blend is heated prior to mechanically alloying .
Patent NO-169511-C (NO)
Inventor: SHAMI A SAID EL
IPC: G01N33/543
Filed: 1987-02-19
Abstract: A method for measuring the level of circulating antigen (Ag1), antibody (Ab1) or hapten (H) in a liquid sample, which comprises forming in a liquid phase reaction a soluble complex wherein said antigen (Ag1) antibody (Ab1) or hapten (H) is linked through, respectively, a specific antibody (Ab), antigen (Ag) or antihapten (Anti-H), to a matrix which is soluble in the liquid phase and carries a ligand (X), subsequently forming an insolubilised complex comprising a solid support linked to the ligand (X) of said soluble complex through an anti-ligand (Y), the insolubilised complex carrying a label (Z) linked to the antigen (Ag1) through an anti-antigen (Anti-Ag1), to the antibody (Ab1) through an anti-antibody (Anti-Ab1) or to the hapten (H), washing the insolubilised complex, and checking the washed insolubilised complex for the presence of the label (Z) to provide a measure of the level of said antigen (Ag1), antibody (Ab1) or hapten (H) in said sample.
Patent NO-166179-C (NO)
Inventor: ALLGEIER HANS
IPC: C07D249/10
Filed: 1987-10-08
Abstract: Aralkyl-4H-1,2,4-triazole derivatives, in particular 5-phenyl(lower alkyl)-4H-1,2,3-triazole-3-carboxamide of the formula 
<IMAGE>
 in which Ph denotes phenyl substituted by lower alkyl, halogen and/or trifluoromethyl, alk represents lower alkylidene, R1 is hydrogen or lower alkyl and R2 represents carbamyl optionally substituted by lower alkyl or lower alkanoyl, and their salts and, if appropriate, their tautomers and salts. These compounds can be used as pharmaceutical active substances.
Patent NO-164051-C (NO)
Inventor: MENGERINGHAUSEN MAX
IPC: E04F15/024
Filed: 1988-06-17
Abstract: In previous composite building slabs for sectional false floors, which are supported at their four corners and consist of an upwardly open trough produced from tension-proof material and of a filling of compression-proof material, e.g. anhydrite, a greater deflection is produced, under load, at the edge of the slab than in the centre of the slab, which is undesirable. In order substantially to even out the load-bearing capacity and security of composite building slabs of the above type against breaking at the edge of and in the centre of the slab, provision is made on the side walls (6g) of the trough (3g) for a reinforcement which is virtually at the height of the slab and is non-positively connected to the base (5) of the trough. In addition or alternatively to this, it is also possible to increase at least twofold the density and strength of the filling (2) in the edge region of the composite building slab (10g) relative to the remaining region towards the centre of the slab. 
<IMAGE>
Patent NO-171978-C (NO)
Inventor: CLARK DAVID ALAN
IPC: C07D417/04
Filed: 1989-02-08
Abstract: Oxazolidin-2-one derivs. of formula (I), corresp. pharmaceutically-acceptable acid addn. salt or pharmaceutically-acceptable cationic salt are new. Rb is (i), (ii) (iii) or (iv), W is S or O; X, X' is H, Cl, F or CF3; Y is -COOR1, -CON(R1)CH2CONR3R3, gp. (v) or vi), Ra, R1, R2, R3 are H, CH3, R4 is CH3 or CF3. For pharmaceutically-acceptable acid addn. salt, Y is gp. (v) or Rb is gp. (iii). For pharmaceutically-acceptable cationic salt y is -COOH or gp. (vi). - Also claimed is an optically active cpd. of formula (I) and use of cpd. (I) as a medicament for the treatment of hyperglycemia.
Patent NO-172146-C (NO)
Inventor: IDE RUSSELL D
IPC: F16C33/22
Filed: 1989-07-04
Abstract: An extrudable multi-durometer hydrodynamic bearing which includes a bearing pad support structure (10) and a plurality of bearing pads (50) fused to the bearing pad support structure (10). The bearing may also include a number of deflection control members (80) fused to the bearing pads and/or the bearing pad support structure. The pad supports of the bearing and movable with six degrees of freedom. The bearing is constructed entirely of non-newtonian fluidic materials and has a constant axial cross-section so that it may be easily extruded. The bearing includes portions having different hardnesses. The method of making the bearing includes the steps of extruding a first material, extruding at least a second material onto the first material prior to curing the first material forming a tubular extrusion, curing the tubular extrusion, cutting the tubular extrusion into bearing segments and sizing the bearing segments by machining the individual bearing segments to the desired inner and outer diameters.
Patent NO-172644-C (NO)
Inventor: KLAUS MICHAEL
IPC: A61K31/385
Filed: 1989-07-13
Abstract: Compounds of the formula 
<IMAGE>
 in which the symbols R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, n, X and Y have the meaning indicated in the description, can be used as medicines for oncological and dermatological indications.
Patent NO-177510-C (NO)
Inventor: MARUYAMA HIROSHI
IPC: G03F1/00
Filed: 1989-07-20
Abstract: A lightsafe masking film is disclosed which comprises a substrate, a pressure sensitive adhesive layer formed on the substrate, and a lightsafe, peelable layer formed on the adhesive layer and including a dialkyl phthalate, nitrocellulose, a lightsafe colorant and, optionally, a filler and a nitrile rubber. The peelable layer further suitably contains a dialkyl ester of an aliphatic dicarboxylic acid.
Patent NO-174536-C (NO)
Inventor: HERRMANN FRITZ
IPC: A61M35/00
Filed: 1989-11-09
Abstract: A reservoir has a release surface for controlled, diminishing release of active substances throughout the period of application to solid, liquid or gaseous acceptors. At at least one position on the reservoir (102), a flat (101) cross-sectional surface of the reservoir is smaller than the release surface. Also described are a device for controlled, diminishing release of active substances throughout the period of application having at least one reservoir (102), and the use of the device disclosed in technology, human and veterinary medicine, cosmetics and pest control, at least one active substance to be released being effective in the field of technology, human and veterinary medicine, cosmetics and pest control.
Patent NO-178636-C (NO)
Inventor: SEM BJARNE
IPC: E04B1/68
Filed: 1993-10-22
Abstract: A tube for chemical injection in concrete, comprising an injection material feed portion (1) and a compressible, porous material (4) attached thereto, where feed portion (1) comprises at least two moulded channels (2), running side by side, preferably in one piece and in the form of strips, in the outer walls of which there are formed microscopic apertures (3) for emission from the interior to the outside at a predetermined interior overpressure.
Patent NO-179604-C (NO)
Inventor: SUNDQUIST TORE
IPC: C09K3/32
Filed: 1994-01-19
Abstract: PCT No. PCT/NO95/00015 Sec. 371 Date Jul. 18, 1996 Sec. 102(e) Date Jul. 18, 1996 PCT Filed Jan. 19, 1995 PCT Pub. No. WO95/19842 PCT Pub. Date Jul. 27, 1995An oil absorbing article is made of an outer covering of wool felt that forms an enclosure containing pine bark. The covering may be in the form of a mat, a pillow, or a boom. The outer covering allows the oil to pass through into the bark, which becomes saturated with the oil. This saturation prevents flow of water to the bark, whereby the article remains floating after absorption of oil.
Patent CA-2012015-C (CA)
Title: Button applicator with safety apparatus
Inventor: ITO KAZUYOSHI
IPC: A41H37/00
Filed: 1990-03-13
Granted: 1993-10-12
Abstract: Button Applicator with Safety Apparatus Abstract of the Disclosure A button applicator with a one-rotation clutch linked to a foot pedal and is released by a disconnecting and connecting mechanism. A safety member is provided between a punch and a die and urged upward. A swing lever is linked to the safety member at its one end and linked to an operation rod connected to the foot pedal at its substantial center and swings about another end of the swing lever. A means for shutting off the clutch is provided between the operation rod and the swing lever. A means for allowing the notation of the clutch is provided between the operation rod and the connecting and disconnecting mechanism. According to a preferred embodiment, the means for allowing the rotation of said clutch comprises an intermediate rod linked to the connecting and disconnecting member and having a stopper at its end and an interconnecting member interconnecting the two rods, and the means for shutting off the clutch comprises a sliding bearing fixed to the swing lever, a collar mounted on the sliding bearing and a spring between the sliding bearing and a rod end. The relational movements of above mentioned two means release the clutch to rotate through the connecting and disconnecting mechanism. Finally, the punch linked to the clutch is brought down for caulking button elements when the operation rod is brought down to a deeper position by a predetermined interval than a predetermined position of the safety member being brought down.
Patent CA-2012790-C (CA)
Title: High voltage power source device
Inventor: SAKAMOTO KAZUHO
IPC: H02M7/48
Filed: 1990-03-22
Granted: 1994-09-27
Abstract: Abstract A high voltage power source device comprises an electric power source; a low voltage circuit constituted by an inverter circuit including a semiconductor switching element and a capacitor for converting electric power from the source into high frequency electric power; a magnetron; and a high voltage transformer for converting the high frequency electric power into high voltage and supplying it to the magnetron.  A printed circuit board has electric wiring formed thereon for connection to and supporting the inverter circuit and a high voltage circuit for the voltage boosted by the high voltage transformer.  The board has separate areas therein, and the low and high voltage circuits are formed respectively on these separate areas.  The board includes a patterned grounding conductor formed at the boundary between the separate areas and also has either a plurality of openings extending completely through the board in alignment with the patterned grounding conductor, or a plurality of generally elongated electroconductive pieces each having opposite ends connected to the patterned grounding conductor.
Patent CA-2014223-C (CA)
Title: Brake release mechanism for a spring applied vehicle park brake
Inventor: MENARD ALBERT A
IPC: B60T7/20
Filed: 1990-04-09
Granted: 1995-09-12
Abstract: A brake release mechanism for a vehicle provided with a main retrieval hook is disclosed.  The brake release mechanism comprises a hydraulic cylinder having its piston rod terminated in the form of a hook which is located within the main retrieval hook of the vehicle, a shuttle valve located in the main hydraulic line interconnecting the regular spring applied brake to a hydraulic pressure supply, and an auxiliary hydraulic line interconnecting the shuttle valve and the hydraulic cylinder for applying fluid pressure to the spring applied brake through the shuttle valve in case of loss of pressure from the regular hydraulic pressure supply.  The above mechanism allows the hook of the piston rod to be engaged at the same time as the regular retrieval hook to disengage the brake while pulling on the stranded vehicle.
Patent CA-2027328-C (CA)
Title: Decoupled sanitary napkin
Inventor: OSBORN THOMAS WARD III
IPC: A61F13/515
Filed: 1990-10-11
Granted: 1994-06-28
Abstract: ABSTRACT OF THE DISCLOSURE      A sanitary napkin having a topsheet and an absorbent core associated with  the  topsheet  is  disclosed.   The  topsheet  and associated core are decoupled from the backsheet of the sanitary napkin so that the topsheet and backsheet may be separated in the Z-direction.   The sanitary napkin has a joined transverse edge connecting the  topsheet  and  backsheet  and  forming  a  hinge  to facilitate  the  Z-direction  separation.   The  sanitary  napkin further controls  the amount  of separation of the topsheet and associated core from the backsheet.  A preferred way to control the amount of separation of the topsheet and associated core from the backsheet is longitudinally oriented pleats.
Patent CA-2027833-C (CA)
Title: Implant material, method for the manufacture thereof and procedure for the application of the material
Inventor: LARSSON KARE
IPC: A61L27/12
Filed: 1990-10-17
Granted: 2003-04-22
Abstract: The invention relates to an implant material composition for restoring bone tissue in a human or animal body. Said compo-sition comprises a particulate biocompatible bone tissue sub-stitute material distributed in a bioacceptable mixture of a) a water-based liquid and b) a monoglyceride and optionally c) a triglyceride, said ingredients a), b) and c) forming an L2-phase or a lamellary liquid crystalline phase and being present in such proportions within said phases that they are capable of being transformed into a cubic liquid crystalline phase or a reversed hexagonal liquid crystalline phase when contacted with an aqueous liquid. Thus, the phase conversion referred to imparts to the composition such a high viscosity that is works as an implant material as defined.  There is also provided a method of preparing said com-position comprising forming the L2 or lamellary phase and distributing the bone tissue substitute material therein.      Moreover, there is provided a method of restoring lost bone tissue comprising applying the composition to a bone cavity and converting the same by contact with an aqueous liquid.      The composition for use as an implant material compo-sition as well ae the use thereof for the manufacture of an implant product are also provided.      Finally the invention relates to the restored implant bone tissue product obtainable from said composition by con-tact with said aqueous liquid.
Patent CA-2041223-C (CA)
Title: Functionally programmable pcm data analyzer and transmitter for use in telecommunication equipment
Inventor: LENIHAN JOHN P
IPC: H04M1/24
Filed: 1991-04-25
Granted: 1995-10-24
Abstract: A digital signal processing system for interfacing with an apparatus for central control having at least a control port comprising control apparatus for processing having an interface port connected to the control port of the central control, the apparatus for processing also having at least first, second and third ports, at least first, second and third kernel apparatus for running software application tasks having first, second and third ports, respectively, connected to the first, second and third ports of the control apparatus for processing, respectively, each of the kernel apparatus having a plurality of channel ports connected to a bus apparatus for providing a plurality of channels, the control apparatus for processing in response to data received from the central control establishing one of a plurality of software application tasks in each of the kernel apparatus.
Patent CA-2051033-C (CA)
Inventor: GIFFORD ERIC
IPC: B65C9/02
Filed: 1991-09-10
Granted: 1996-03-12
Abstract: An apparatus and method are disclosed for labeling bottles in a stream.  An input conveyor is provided for supplying bottles to a presenting station.  Bottles are restrained at the presenting station until the ap-propriate time by an entrance gate.  Bottles are conveyed from the presenting station to a work station by an advancing conveyor.  Bottles entering the work station drive the predecessor bottle out of the work station.  An exit gate is provided to halt bottles leaving the work station so that they act as a registra-tion stop for bottles entering the work station.